Goal: To illustrate how the successive use of a continuous quality improvement program for maintaining and improving an intravenous iron and anemia management protocol can improve patient outcomes.
Objectives:
Describe the revision of an anemia management protocol in the context of an established CQI process.
Explain how evidence-based literature on erythropoietin-stimulating agents and IV iron therapy should be used to drive CQI revision.
Evaluate the effects on patient outcomes of a revised anemia management protocol using the CQI process.
Acknowledgments: The author acknowledges the assistance of David S. MacDougall and Liz Turrin in the preparation of this manuscript. Writing assistance was provided with support from Watson.
Disclosure Statement: The author reported that she is on the Watson Pharmaceuticals Speakers' Bureau.
Note: This article is supported by a financial grant from Watson Pharma, Inc. This article has undergone peer review. The information in this article does not necessarily reflect the opinions of ANNA or the sponsor.
